Piper Jaffray Upgrades Arena Pharma (ARNA) to Overweight

May 11, 2012 11:23 AM EDT Send to a Friend
Get Alerts ARNA Hot Sheet
Price: $4.15 +1.22%

Rating Summary:
    4 Buy, 9 Hold, 5 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 24 | Down: 28 | New: 14
Trade ARNA Now!
Join SI Premium – FREE
Piper Jaffray upgraded Arena Pharma (NASDAQ: ARNA) from Neutral to Overweight, price target boosted from $2.50 to $7.00.

For an analyst ratings summary and ratings history on Arena Pharma click here. For more ratings news on Arena Pharma click here.

Shares of Arena Pharma closed at $3.66 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change, Upgrades

Related Entities

Piper Jaffray

Add Your Comment